TNFRSF1A and T-cell non-Hodgkin lymphoma: According to Heemann et al. 13, elevations of circulating levels of TNFR and high circulating levels of soluble TNFR2 are negative predictors of treatment response in T-cell non-Hodgkin lymphomas.